216 The vasculo-protective effect of candesartan after ischemic stroke: an Antioxidant

Tuesday, October 23, 2012
Westin Diplomat Resort
Ahmed Alhusban, Pharm.D1, Anna Kozak, M.S.2, Tauheed Isharat, Ph.D.3, Bindu Pillai, MS3 and Susan C. Fagan, PharmD3
1University of Georgia, Augusta, GA
2University of Georgia College of Pharmacy and Veteran's Affairs Medical Center, Augusta, GA
3Program in Clinical and Experimental Therapeutics University of Georgia College of Pharmacy Charlie Norwood VA Medical Center Au, Augusta, GA

Purpose: Angiotensin II receptor blockers (ARBs) have been found to have antioxidant effects and to reduce vascular injury after stroke, but whether the two are causally related is unclear.

Methods: 40 hypertensive rats (SHR) were treated with either candesartan 1 mg/kg or saline after 3 hours of middle cerebral artery occlusion (MCAO) and were reperfused for 21 hours prior to sacrifice. An additional group (n=16), were treated with the SOD mimetic, tempol, for 2 weeks prior to the same procedure. After saline perfusion, brain tissue was collected for quantification of excess hemoglobin, and biochemical analyses. 

Results: Treatment with tempol and candesartan significantly reduced the blood pressure, but the effect of tempol was less pronounced than candesartan. Candesartan 1mg/kg significantly reduced hemorrhagic transformation (HT) in SHR animals after stroke (p<0.05). Animals treated with tempol had significantly lower incidence of HT than controls and this was NOT further reduced by candesartan (p=0.01). Candesartan treatment significantly increased the expression of eNOS in stroked hemisphere (p<0.05) a response that was lost in those treated with tempol. In contrast, the p-eNOS /eNOS ratio was significantly increased in animals treated with candesartan and tempol combination, compared to either alone (p<0.5).  

Conclusion: Acutely administered candesartan reduces HT in SHRs at 24 hours after MCAO by an antioxidant mechanism.